Loading clinical trials...
Loading clinical trials...
An Observational Study of Avastin® (Bevacizumab) in Combination With Chemotherapy for Treatment of First-line Metastatic Colorectal Adenocarcinoma
Conditions
Interventions
Bevacizumab
Capecitabine/Oxaliplatin
+4 more
Locations
43
United Kingdom
Royal United Hospital Bath; Diabetes and Lipid Research, Wolfson Centre
Bath, United Kingdom
Wexham Park Hospital; Oncology
Berkshire, United Kingdom
Queen Elizabeth Hospital
Birmingham, United Kingdom
Birmingham Heartlands Hospital; Dept of Oncology
Birmingham, United Kingdom
Bishop Auckland Hospital;Oncology Department
Bishop Auckland, United Kingdom
University Hospital of North Staffordhire
Blackpool, United Kingdom
Start Date
July 6, 2012
Primary Completion Date
March 10, 2017
Completion Date
March 10, 2017
Last Updated
May 14, 2018
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions